We discovered that JAK2-mutated cancers displayed greater expression of proinflammatory chemotactic factors (Fig. 5C), which have been shown to attract CD8+ T cells [37], and their expression is increased when the JAK signaling pathway is activated [38]. The gene discussed is CD8A; the disease is cancer.